Skip to main content
Caplight Logo









Rhyme

Rhyme

Private
New Albany, OhioHealthcare & Life Scienceshttps://getrhyme.com/

Last Round

Series C

Feb 14, 2022

Total Funding Raised

$50.78M

Company Overview

Rhyme is a healthcare technology company that provides an integrated prior authorization network platform to streamline communication between payors and providers.

Sector

Healthcare & Life Sciences

Verticals

Compliance & Risk, Workflow Automation, Document Management, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Keywords

clinical document managementregulatory submissionclinical trial softwareeTMFelectronic trial master fileregulatory affairs softwareworkflow automationlife sciences SaaSclinical research organizationCROdocument indexingpharma techregulatory complianceprior authorizationhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Rhyme Comparables

Compare Rhyme with similar companies based on industry and business-model similarity.

Rhyme comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DrFirst
48%
Tennr
48%
Coherence Health
44%

Rhyme Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CFeb 14, 2022
Series BOct 1, 2020
Series AMay 15, 2018
SeedAug 29, 2017
SeedApr 26, 2017
Seed
Oct 1, 2015

Key People

Founding team and executive leadership

Joe Anstine

CEO

Executive Team

Jay Sandhaus

COO, CTO

Executive Team

Mike Blackwell

CPO

Executive Team

Rhyme Investors

Notable investors and investment history

Rhyme investors
InvestorRounds
Health2047Series C
BIP CapitalSeries B, Series A
Rev1 VenturesSeed
Detroit Venture PartnersSeries A, Seed, Series B
NCT VenturesSeries A, Series B, Seed
Insight PartnersSeries C, Series B
Panoramic VenturesSeries C, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 14, 2022

    $25M round led by Insight Partners

  • May 15, 2018

    Raised $11M led by BIP Capital and Panoramic Ventures

Rhyme Filings

Explore SEC and related filing metadata, where available.

Rhyme filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Rhyme's valuation, stock price, and market status.

Is Rhyme a public or private company?

Rhyme is a private company.

What is the current stock price of Rhyme?

Rhyme is a private company with no public stock price. No recent secondary market data is available.

How much is Rhyme worth (valuation)?

Valuation information for Rhyme is not publicly available.

Can I buy Rhyme stock?

Rhyme shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Rhyme's last funding round?

Rhyme's most recent funding round was Series C on February 14, 2022.

Who are the main investors in Rhyme?

Key investors in Rhyme include BIP Capital, NCT Ventures, Insight Partners.

Will Rhyme IPO soon?

No public IPO plans have been announced for Rhyme.

How can I track Rhyme secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rhyme's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew Albany, Ohio
Employee Range56
Year Founded2014
Last FundingFeb 14, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?